dihexa human trials safety Synapse (Dihexa) Cognitive Peptide Therapy

Dawn Ericsson, MD, alongside a clinical team experienced in supervised peptide protocols

\n\n\n\n These findings have generated genuine scientific interest in BPC-157 as a potential candidate for further development in IBD research, though the absence of human clinical trials means that clinical applicability remains to be established

Conversely, ultrasonography can result in compression effects due to the use of the ultrasound probe, potentially leading to misinterpretation of the thicknesses of the skin and subcutaneous layers

Several peptides being studied for autoimmune applications work specifically at this gut-immune interface